This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (32)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Francine J. Vriesendorp, MD; Richard F. Mayer, MD; Carol L. Koski, MD

Arch Neurol. 1991;48(8):858-861.

Abstract
• Serial anti-peripheral nerve myelin antibody titers were determined in 28 consecutive patients with Guillain-Barré syndrome during the course of their illness. Eighteen patients were treated with plasmapheresis and 10 were not. Anti-peripheral nerve myelin antibody titers in the group treated with plasmapheresis declined significantly more rapidly than in the group not treated with plasmapheresis. Five patients treated with plasmapheresis who showed initial clinical improvement, with a concurrent decline in anti-peripheral nerve myelin antibody titer, had one or two recurrences of clinical symptoms during a 2- to 8-week period associated with an increase in anti-peripheral nerve myelin antibody titer. Recurrent weakness was severe enough to prompt additional courses of plasmapheresis. The data suggest that serial determinations of antiperipheral nerve myelin antibody in patients with Guillain-Barré syndrome may identify patients with antibody rebound associated with recurrence of clinical symptoms and prolonged recovery in whom further plasmapheresis should be considered.

Author Affiliations
From the Department of Neurology, University of Maryland School of Medicine (Drs Vriesendorp, Mayer, and Koski), and the Department of Veterans Affairs Medical Center (Dr Vriesendorp), Baltimore, Md.

Footnotes
Accepted for publication December 13, 1990.

Read in part before the 41st Annual Meeting of the American Academy of Neurology, Chicago, Ill, April 16,1989.

Reprint requests to the Department of Neurology, University of Maryland Hospital, 22 S Greene St, Baltimore, MD 21201 (Dr Vriesendorp).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Therapeutic Apheresis in Neurology Critical Care
Natarajan and Weinstein
J Intensive Care Med 2005;20:212-225.
ABSTRACT  

Use of Cellular and Plasma Apheresis in the Critically Ill Patient: Part II: Clinical Indications and Applications
Linenberger and Price
J Intensive Care Med 2005;20:88-103.
ABSTRACT  

Motor root conduction in neuralgic amyotrophy: evidence of proximal conduction block
Lo and Mills
J. Neurol. Neurosurg. Psychiatry 1999;66:586-590.
ABSTRACT | FULL TEXT  

Anti-Peripheral Nerve Myelin Antibodies and Terminal Activation Products of Complement in Serum of Patients With Acute Brachial Plexus Neuropathy
Vriesendorp et al.
Arch Neurol 1993;50:1301-1303.
ABSTRACT